Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT04846920 |
| Title | A Study of Belzutifan (MK-6482) in Participants With Advanced Clear Cell Renal Cell Carcinoma (MK-6482-018) |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme Corp. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Beth Israel Deaconess Medical Center ( Site 1002) | Boston | Massachusetts | 02215 | United States | Details | |
| University of Michigan ( Site 1006) | Ann Arbor | Michigan | 48109 | United States | Details | |
| Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 1005) | Nashville | Tennessee | 37232 | United States | Details | |
| University of Texas MD Anderson Cancer Center-Genitourinary Medical Oncology ( Site 1007) | Houston | Texas | 77030 | United States | Details |